Brief: GSK Says US FDA Approves Hibsago For Chronic Hepatitis B
Yesterday 07:15
BRIEF-GSK Says US FDA Approves Hibsago For Chronic Hepatitis B Oct 21 (Reuters) - GSK plc GSK.L:
GSK PLC - US FDA APPROVES HIBSAGO FOR CHRONIC HEPATITIS B
GSK PLC - US FDA APPROVES HIBSAGO FOR CHRONIC HEPATITIS B
GSK: GSK CONTINUES TO ADVANCE REGULATORY SUBMISSIONS FOR BEPIROVIRSEN ACROSS MULTIPLE GEOGRAPHIES
Source text: ID:nRSU7766Za
Further company coverage: GSK.L
((Reuters.Briefs@thomsonreuters.com;))